Sara L. Van Driest

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy

Sara L. Van Driest, Vlad C. Vasile, Steve R. Ommen et al. · Journal of the American College of Cardiology · 2004 · 426 citations

Cardiac Muscle, Cardiomyopathy, Heart Failure +11

Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between

Gail P. Jarvik, Laura M. Amendola, Jonathan S. Berg et al. · The American Journal of Human Genetics · 2014 · 368 citations · Full text

Genomic Results, Genetic Testing, Research Participants +9

Clinical Pharmacogenetics Implementation Consortium Guideline for <i>CYP2D6</i>, <i>OPRM1</i>, and <i>COMT</i> Genotypes and Select Opioid Therapy

Kristine R. Crews, Andrew A. Monte, Rachel Huddart et al. · Clinical Pharmacology & Therapeutics · 2021 · 366 citations · Full text

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C19</i> and Proton Pump Inhibitor Dosing

John J. Lima, Cameron D. Thomas, Julia M. Barbarino et al. · Clinical Pharmacology & Therapeutics · 2020 · 281 citations · Full text

Phenotype risk scores identify patients with unrecognized Mendelian disease patterns

Lisa Bastarache, Jacob Hughey, Scott J. Hebbring et al. · Science · 2018 · 235 citations

Genome-wide Association Study, Mendelian Disorder, Genotype-phenotype Association +15